Word

NDURE

Status

Dead

Status Code

602

Status Date

Monday, August 19, 2024

Serial Number

79379393

Mark Type

4

Filing Date

Wednesday, April 19, 2023

Abandoned Date

Tuesday, August 6, 2024

Trademark Owner History

Elasmogen Ltd

Classifications

5 Pharmaceutical preparations; biological preparations for medical purposes; diagnostic preparations and materials; therapeutic preparations and substances; anti-angiogenesis preparations; anti-cancer preparations; anti-inflammatory preparations; pharmaceutical and biochemical preparations for the treatment or prevention of cancer, infectious disease, physiological disorders, hormonal disorders, inherited disease, single gene disorders, respiratory diseases, gastro-intestinal disorders, circulatory disorders, dermatological conditions, immuno-deficiencies, organ damage, cell proliferation, peripheral neurological disorders, genitourinary disorders, musculoskeletal disorders, and blood disorders; diagnostic reagents for medical use; DNA, antibodies and proteins for medical use; DNA and/or antibodies and/or proteins that stimulate cells for medical use; DNA, antibodies and proteins for therapeutic use; diagnostic products and reagents for medical use

42 Medical and pharmacological research services; scientific and technological services and research and design relating thereto; scientific research for medical purposes; pharmaceutical research and development services; pharmaceutical testing; research and development in the biotechnology field; research and development services in the field of antibodies; biotechnology services; conducting clinical trials; biological research, clinical research and medical research; providing information about the results of clinical trials for pharmaceutical products; analytic and diagnostic research and laboratory services in the field of science; development of assays, both for products and analysis, provided for others; laboratory services; research and development of new products for others; research and scientific analysis relating to drug discovery, as well as development thereof for others; scientific advisory services; scientific consultancy; scientific research and development; scientific research in the field of biotechnology and pharmaceuticals; management of scientific research projects; issuing of scientific information; advisory services relating to scientific and clinical research; provision of information and consultancy in relation to the aforesaid services

ENDURE

Trademark Events

Sep 28, 2023

Sn Assigned For Sect 66a Appl From Ib

Sep 29, 2023

New Application Office Supplied Data Entered

Oct 3, 2023

Application Filing Receipt Mailed

Nov 11, 2023

Correction Transaction Received From Ib

Jan 17, 2024

Assigned To Examiner

Jan 2, 2024

Correction From The Ib Examined, No Action Is Needed

Jan 18, 2024

Non-Final Action (Ib Refusal) Prepared For Review

Jan 17, 2024

Non-Final Action Written

Jan 18, 2024

Non-Final Action (Ib Refusal) Withdrawn For Review

Feb 27, 2024

Refusal Processed By Ib

Jan 18, 2024

Non-Final Action Written

Jan 19, 2024

Non-Final Action (Ib Refusal) Prepared For Review

Feb 5, 2024

Refusal Processed By Mpu

Feb 5, 2024

Non-Final Action Mailed - Refusal Sent To Ib

Aug 19, 2024

Abandonment - Failure To Respond Or Late Response

Aug 19, 2024

Abandonment Notice Mailed - Failure To Respond